Trial intelligence / Profile preview

Bupropion and Citalopram in an Individual With Friedreich Ataxia

NCT01716221Phase 4Completed

Sponsor
University of Colorado Denver
Start
Oct 2012
Primary completion
Mar 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of bupropion, citalopram in Friedreich ataxia (FA), sponsored by University of Colorado Denver. Started Oct 2012; status: completed.

02

Drugs

bupropioncitalopram
03

Conditions

Friedreich ataxia (FA)

Beyond the preview

Go deeper on NCT01716221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01716221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call